What is the Projected CAGR value of the Asthma and COPD Drug Market ?
The Global Asthma and COPD Drug Market are expected to grow at a CAGR of 3.9% during the forecast period (2024-2031).
Who are the Key Players of Asthma and COPD Drug Market ?
Major players are AstraZeneca PLC, Boehringer Ingelheim GmbH, GlaxoSmithKline PLC, Novartis AG, Hoffmann-La Roche Ltd, Pfizer Inc., Grifols SA, Merck & Co. Inc., Sanofi SA and Sumitomo Dainippon Pharma Co. Ltd.